Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

Communications Biology

Author Correction

Sung Yun Jung¹  Qi Wang²  Jing Wang²  Min Jin Ha³  Huiqin Chen⁴  Victor Olivas⁵  Trever G. Bivona⁶  Franziska Haderk⁶  Philippe Gui⁶  Elizabeth Shpall⁷  Feng Meng⁸  Feng Li⁸  Mourad Majidi⁸  Bingliang Fang⁸  Lihui Gao⁸  Renduo Song⁸  Ismail M. Meraz⁸  Jack A. Roth⁸  Yonathan Lissanu⁸  RuPing Shao⁸  Jonathan Wesley Riess⁹ 

[1] Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA;Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, Korea;Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Medicine, University of California, San Francisco, San Francisco, CA, USA;Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA;Department of Medicine, University of California, San Francisco, San Francisco, CA, USA;Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA;Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA;Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA;

关键词: ;   

DOI  :  10.1038/s42003-023-04979-9

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2023